Marc Riffet
Caen, 14000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinicopathological and prognostic validation of pulmonary carcinoid/NET G3: evidence for a distinct subgroup of well-differentiated neuroendocrine neoplasms.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 15, 2026
The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption?
Journal: Translational oncology
Published: November 19, 2025
NDR2 regulates non-small cell lung cancer cell migration under starvation by supporting autophagosome biogenesis through LC3 and ATG9A regulation.
Journal: Cell death discovery
Published: August 22, 2025
Establishment of a clear cell renal cell carcinoma organoid cohort integrated into the UroCCR clinical database: A feasibility study.
Journal: Translational oncology
Published: June 12, 2025
A curious histological pattern of the vas deferens
Journal: Annales de pathologie
Published: May 30, 2023
New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding.
Journal: International journal of molecular sciences
Published: December 02, 2022
Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers.
Journal: Cancers
Published: October 19, 2021
Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer.
Journal: The American journal of case reports
Published: August 16, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026